Serious violations, false nbsp pharmaceutical enterprises; "forbid into"

Japan held a State Council Executive meeting discussed and adopted. one of the highlights being the parties concerned: pharmaceutical enterprises credit rank appraisal, of serious violations, false, they will be "banned". It goes without saying, China's drug safety is now at risk-prone period. over the years, "houttuynia cordata" events, "xinfu" events, "Siberian" event sth Again and again sting with public of neural, behind exposed of is production, and sales, and regulatory links in the of violations default; and drug of "virtual high" also has been is criticized: some proprietary Chinese medicines added has Western medicine components, is was boasting into "hundred min hundred pure Chinese medicine, no HIV side effects"; some drug at every turn wear "latest results", and "expert recommended" of hat, spoof consumer Pocket sth sth Compared with other industries manufacturing enterprises, particularity of drug-production and sales enterprises is that, even though "occasionally" one time violation actions and breaking behavior of losing, injury is difficult to restore the health and hygiene
Life. as a result, the "safety first" is the industry choice principle; and "forbid into" such measures to alert the enterprise, it is necessary to reduce security risks.　　But, many case also display, to let more drug enterprises habits Yu told credit, and to good closed, alone by moral self-discipline I'm afraid no, must established a standardization of industry credit evaluation system, with system of forces to penal evil Yang good, formed told rules told credit of medicine market environment; alone by ban of AWE I'm afraid also also enough, more must beware "banner light", only real check really ban, let bad enterprise pay high cost, to let all drug enterprises can't lightly. In many cases, in the case of drug companies, punishing "bad guy" would be tantamount to protecting "good." if those bad faith, in serious violation of pharmaceutical enterprises operators, able to dominate the market, get "success", then to other operators, would be a serious hidden damage, "reverse incentive" effect
More drug enterprises tide, resulting in loss of credit in a larger context. Actually, some local has began realized that this problem. in Zhejiang, this year May has started has related of credit evaluation informed system, publicity has group of serious breaking of drug wholesale enterprise, this to more large range within promoting drug industry integrity institutionalized Mai opened has important a step. but, carried out medicine enterprise credit grade evaluation also just first step, it is can played good of reality effect, will depends on can to more of details to protection implementation effect. to what standard evaluation credit? by who to evaluation? By what process to evaluate the? how serious breaches promise truly "banned in" sth　　Answer these questions, will make a good system design into good management practice. Of course, must also "make up" and "tube", to create a favorable external environment for pharmaceutical enterprises. let their good faith, without fraud, bribery, also can rely on quality